PMC:7170368 / 8789-9307 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"215","span":{"begin":103,"end":106},"obj":"Gene"},{"id":"216","span":{"begin":216,"end":220},"obj":"Gene"},{"id":"217","span":{"begin":225,"end":228},"obj":"Gene"},{"id":"218","span":{"begin":280,"end":283},"obj":"Gene"},{"id":"219","span":{"begin":290,"end":293},"obj":"Gene"}],"attributes":[{"id":"A215","pred":"tao:has_database_id","subj":"215","obj":"Gene:1636"},{"id":"A216","pred":"tao:has_database_id","subj":"216","obj":"Gene:3569"},{"id":"A217","pred":"tao:has_database_id","subj":"217","obj":"Gene:1401"},{"id":"A218","pred":"tao:has_database_id","subj":"218","obj":"Gene:920"},{"id":"A219","pred":"tao:has_database_id","subj":"219","obj":"Gene:925"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":243,"end":248},"obj":"Body_part"},{"id":"T23","span":{"begin":297,"end":302},"obj":"Body_part"},{"id":"T24","span":{"begin":317,"end":322},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T19","span":{"begin":243,"end":248},"obj":"Body_part"},{"id":"T20","span":{"begin":317,"end":322},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T75","span":{"begin":85,"end":88},"obj":"Disease"},{"id":"T76","span":{"begin":107,"end":110},"obj":"Disease"}],"attributes":[{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0012733"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0012733"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T67","span":{"begin":119,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T68","span":{"begin":199,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T69","span":{"begin":243,"end":248},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T70","span":{"begin":243,"end":248},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T71","span":{"begin":274,"end":277},"obj":"http://purl.obolibrary.org/obo/CLO_0052882"},{"id":"T72","span":{"begin":274,"end":277},"obj":"http://purl.obolibrary.org/obo/CLO_0053434"},{"id":"T73","span":{"begin":280,"end":283},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T74","span":{"begin":290,"end":293},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T75","span":{"begin":295,"end":302},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T76","span":{"begin":317,"end":322},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T77","span":{"begin":317,"end":322},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T78","span":{"begin":463,"end":471},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T90","span":{"begin":89,"end":94},"obj":"Chemical"},{"id":"T91","span":{"begin":111,"end":116},"obj":"Chemical"},{"id":"T92","span":{"begin":216,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A93","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}

{"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":0,"end":402},"obj":"Sentence"},{"id":"T75","span":{"begin":403,"end":448},"obj":"Sentence"},{"id":"T76","span":{"begin":449,"end":518},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Summarized clinical, inflammatory, immunological, and viral findings in the non-ACEI/ARB group and the ACE/ARB group. (A) The disease severity distribution of the two groups during hospitalization. (B) The levels of IL-6 and CRP in peripheral blood. (C) Absolute numbers of CD3+, CD4+, and CD8+ T cells in peripheral blood. (D) Viral load on hospital admission and maximum value during hospitalization. The data are expressed as the median and IQR. An unpaired t test was used, and P \u003c 0.05 was considered significant."}